{"url":"https://lda.senate.gov/api/v1/filings/f13bfb1a-7d2b-45bb-b279-e5db7606ad79/","filing_uuid":"f13bfb1a-7d2b-45bb-b279-e5db7606ad79","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2017,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/f13bfb1a-7d2b-45bb-b279-e5db7606ad79/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Tom Loranger","dt_posted":"2018-01-23T10:44:50.803000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"750 9th Street, NW","registrant_address_2":"Suite 750","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":22325,"url":"https://lda.senate.gov/api/v1/registrants/22325/","house_registrant_id":32268,"name":"THE PAUL LAXALT GROUP","description":"Lobbying Firm","address_1":"750 9th Street, NW","address_2":"Suite 750","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TOM LORANGER","contact_telephone":"+1 202-441-7089","dt_updated":"2022-04-06T16:06:10.188797-04:00"},"client":{"id":129228,"url":"https://lda.senate.gov/api/v1/clients/129228/","client_id":404,"name":"THE ROGOSIN INSTITUTE","general_description":"Not-For-Profit hospital that specializes in kidney care and research.","client_government_entity":false,"client_self_select":null,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-06-10"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Legislation and Regulation Relating to Medicare polices relating to kidney care. \nHR 2644, The Chronic Kidney Disease Improvement in Research and Treatment Act of 2017","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":19765,"prefix":null,"prefix_display":null,"first_name":"TOM","nickname":null,"middle_name":null,"last_name":"LORANGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Monitor issues concerning improvements in medical research and treatment of kidney disease. \nCreating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017 - S. 870\nH.R.4143 - Dialysis PATIENTS Demonstration Act of 2017","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":19765,"prefix":null,"prefix_display":null,"first_name":"TOM","nickname":null,"middle_name":null,"last_name":"LORANGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}